NYSE:CHE - Chemed Stock Price, News, & Analysis

$346.35
+0.90 (+0.26 %)
(As of 06/19/2019 11:38 AM ET)
Today's Range
$343.98
Now: $346.35
$348.23
50-Day Range
$321.56
MA: $335.60
$351.55
52-Week Range
$260.03
Now: $346.35
$354.43
Volume1,222 shs
Average Volume85,753 shs
Market Capitalization$5.52 billion
P/E Ratio28.90
Dividend Yield0.35%
Beta1.11
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Read More…

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.78 billion
Cash Flow$15.0391 per share
Book Value$36.93 per share

Profitability

Net Income$205.54 million

Miscellaneous

Employees15,707
Market Cap$5.52 billion
Next Earnings Date7/24/2019 (Estimated)
OptionableOptionable

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

Chemed (NYSE:CHE) Frequently Asked Questions

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Monday, May 20th. Stockholders of record on Thursday, May 30th will be paid a dividend of $0.30 per share on Wednesday, June 19th. This represents a $1.20 annualized dividend and a dividend yield of 0.35%. The ex-dividend date of this dividend is Wednesday, May 29th. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed announced that its board has authorized a stock repurchase program on Wednesday, March 7th 2018, which permits the company to buyback $150,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback programs are often an indication that the company's board of directors believes its stock is undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its quarterly earnings data on Monday, April, 29th. The company reported $2.92 earnings per share for the quarter, missing analysts' consensus estimates of $2.96 by $0.04. The company had revenue of $462.03 million for the quarter, compared to analyst estimates of $468.28 million. Chemed had a return on equity of 35.19% and a net margin of 11.37%. Chemed's quarterly revenue was up 5.2% compared to the same quarter last year. During the same quarter last year, the business earned $2.72 earnings per share. View Chemed's Earnings History.

When is Chemed's next earnings date?

Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, July 24th 2019. View Earnings Estimates for Chemed.

What guidance has Chemed issued on next quarter's earnings?

Chemed issued an update on its FY19 earnings guidance on Monday, April, 29th. The company provided earnings per share guidance of $12.65-12.85 for the period, compared to the Thomson Reuters consensus estimate of $12.78. Chemed also updated its FY 2019 guidance to $12.65-12.85 EPS.

What price target have analysts set for CHE?

3 Wall Street analysts have issued 1-year price objectives for Chemed's shares. Their predictions range from $318.00 to $390.00. On average, they anticipate Chemed's share price to reach $359.3333 in the next year. This suggests a possible upside of 3.7% from the stock's current price. View Analyst Price Targets for Chemed.

What is the consensus analysts' recommendation for Chemed?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.

Has Chemed been receiving favorable news coverage?

News stories about CHE stock have trended somewhat positive this week, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Chemed earned a coverage optimism score of 1.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Chemed.

Are investors shorting Chemed?

Chemed saw a drop in short interest during the month of May. As of May 15th, there was short interest totalling 187,800 shares, a drop of 16.5% from the April 15th total of 224,900 shares. Based on an average daily trading volume, of 121,700 shares, the short-interest ratio is presently 1.5 days. Approximately 1.2% of the shares of the company are sold short. View Chemed's Current Options Chain.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include Home Depot (HD), Vertex Pharmaceuticals (VRTX), Altria Group (MO), Fortinet (FTNT), GW Pharmaceuticals PLC- (GWPH), Micron Technology (MU), Boeing (BA), BlackRock (BLK), CVS Health (CVS) and Walt Disney (DIS).

Who are Chemed's key executives?

Chemed's management team includes the folowing people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
  • Mr. David P. Williams, Exec. VP & CFO (Age 58)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
  • Mr. Spencer S. Lee, Exec. VP (Age 63)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 40)

Who are Chemed's major shareholders?

Chemed's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.38%), Neuberger Berman Group LLC (4.09%), Acadian Asset Management LLC (3.43%), Riverbridge Partners LLC (2.72%), FMR LLC (1.96%) and Investec Asset Management LTD (1.58%). Company insiders that own Chemed stock include David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice. View Institutional Ownership Trends for Chemed.

Which institutional investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including MERIAN GLOBAL INVESTORS UK Ltd, Riverbridge Partners LLC, Bank of Montreal Can, Boston Partners, Acadian Asset Management LLC, Gabelli Funds LLC, Robeco Institutional Asset Management B.V. and Neuberger Berman Group LLC. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice. View Insider Buying and Selling for Chemed.

Which institutional investors are buying Chemed stock?

CHE stock was purchased by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, AJO LP, Ellis Investment Partners LLC, Ellis Investment Partners LLC, FMR LLC, Los Angeles Capital Management & Equity Research Inc., Fort Washington Investment Advisors Inc. OH and Martingale Asset Management L P. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $346.35.

How big of a company is Chemed?

Chemed has a market capitalization of $5.52 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.View Additional Information About Chemed.

What is Chemed's official website?

The official website for Chemed is http://www.chemed.com/.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.


MarketBeat Community Rating for Chemed (NYSE CHE)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  240 (Thanks for Voting!)
Underperform Votes:  318 (Thanks for Voting!)
Total Votes:  558
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Featured Article: Forex

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel